Hi everyone
As of November 25 , Acalabrutinib has been approved as a mono therapy for second line treatment in France for patients not doing well on Ibrutinib.
My wife Gabriella had to stop Ibrutinib last January after a year because of muscle back pain and heavy bleeding and will resume treatment in the following days with this new drug .
I will keep you informed of her progress
Happy holidays and bless you all
Serge